Isenberg D A, Shoenfeld Y, Madaio M P, Rauch J, Reichlin M, Stollar B D, Schwartz R S
Lancet. 1984 Aug 25;2(8400):417-22. doi: 10.1016/s0140-6736(84)92904-0.
Monoclonal anti-DNA antibodies prepared by the hybridoma technique were used for an analysis of idiotypes of anti-DNA antibodies in systemic lupus erythematosus (SLE). Serum levels of one idiotypic marker, 16/6/R, were higher than normal in 40 of 74 patients (54%) with active SLE, compared with only 6 of 24 patients (25%) with inactive SLE, 9 of 38 patients (25%) with rheumatoid arthritis, and 4 of 96 normal subjects (4%). Levels of the 16/6/R idiotypic marker were determined in serially collected serum samples from 12 patients with SLE. Concordance was found between idiotype levels and clinical activity in 8 of the 12 patients. Levels of the 16/6/R idiotype tended to correlate with levels of antibodies to double-stranded DNA, but in some cases the clinical status was reflected better by the idiotype levels than by the levels of anti-double-stranded-DNA antibodies. Measurement of idiotypes of anti-DNA antibodies may provide information valuable in monitoring the clinical course of patients with SLE.
采用杂交瘤技术制备的单克隆抗DNA抗体,用于分析系统性红斑狼疮(SLE)患者抗DNA抗体的独特型。在74例活动期SLE患者中,有40例(54%)血清中一种独特型标志物16/6/R的水平高于正常,相比之下,24例非活动期SLE患者中只有6例(25%)、38例类风湿关节炎患者中有9例(25%)以及96例正常受试者中有4例(4%)高于正常。对12例SLE患者连续采集的血清样本测定了16/6/R独特型标志物的水平。12例患者中有8例独特型水平与临床活动度一致。16/6/R独特型水平往往与抗双链DNA抗体水平相关,但在某些情况下,独特型水平比抗双链DNA抗体水平更能反映临床状态。测定抗DNA抗体的独特型可能为监测SLE患者的临床病程提供有价值的信息。